ANI Pharmaceuticals Inc (ANIP)
55.82
+0.72
(+1.31%)
USD |
NASDAQ |
Nov 21, 16:00
55.82
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Price to Book Value: 2.890 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.853 |
| November 19, 2024 | 2.883 |
| November 18, 2024 | 2.860 |
| November 15, 2024 | 2.929 |
| November 14, 2024 | 3.05 |
| November 13, 2024 | 3.098 |
| November 12, 2024 | 3.158 |
| November 11, 2024 | 3.197 |
| November 08, 2024 | 3.181 |
| November 07, 2024 | 3.023 |
| November 06, 2024 | 3.024 |
| November 05, 2024 | 2.967 |
| November 04, 2024 | 2.900 |
| November 01, 2024 | 3.013 |
| October 31, 2024 | 2.971 |
| October 30, 2024 | 3.037 |
| October 29, 2024 | 3.063 |
| October 28, 2024 | 3.009 |
| October 25, 2024 | 3.027 |
| October 24, 2024 | 3.077 |
| October 23, 2024 | 3.064 |
| October 22, 2024 | 3.118 |
| October 21, 2024 | 3.077 |
| October 18, 2024 | 3.130 |
| October 17, 2024 | 3.120 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.096 |
| October 15, 2024 | 3.042 |
| October 14, 2024 | 3.036 |
| October 11, 2024 | 2.966 |
| October 10, 2024 | 2.860 |
| October 09, 2024 | 2.944 |
| October 08, 2024 | 2.948 |
| October 07, 2024 | 2.898 |
| October 04, 2024 | 3.002 |
| October 03, 2024 | 2.948 |
| October 02, 2024 | 2.984 |
| October 01, 2024 | 3.087 |
| September 30, 2024 | 3.096 |
| September 27, 2024 | 2.712 |
| September 26, 2024 | 2.690 |
| September 25, 2024 | 2.643 |
| September 24, 2024 | 2.700 |
| September 23, 2024 | 2.772 |
| September 20, 2024 | 2.753 |
| September 19, 2024 | 2.786 |
| September 18, 2024 | 2.817 |
| September 17, 2024 | 2.771 |
| September 16, 2024 | 2.593 |
| September 13, 2024 | 2.700 |
| September 12, 2024 | 2.591 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.239
Minimum
Jun 16 2022
4.452
Maximum
Dec 23 2021
2.417
Average
2.253
Median
Price to Book Value Benchmarks
| Windtree Therapeutics Inc | 0.0851 |
| Allogene Therapeutics Inc | 0.9540 |
| AIM ImmunoTech Inc | 4.627 |
| Protalix BioTherapeutics Inc | 3.791 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.946 |
| Price to Free Cash Flow | 14.68 |
| Price | 55.82 |
| Earnings Yield | -1.02% |
| Market Cap | 1.173B |
| Operating PE Ratio | 112.59 |